Clinical Trial Update: Inflammation, Autonomic Dysfunction and Airway Disease

View source ↗

Summary

NHLBI-sponsored clinical trial examining inflammation, autonomic dysfunction and airway disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Bronchitis
• Lung Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Lung Diseases, Asthma | Status: COMPLETED